Skip to main content
Erschienen in: Tumor Biology 10/2014

01.10.2014 | Research Article

Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7

verfasst von: Kandasamy Palanivel, Veerasamy Kanimozhi, Balamuthu Kadalmani

Erschienen in: Tumor Biology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Verrucarin A (VA), an active constituent of pathogenic fungus Myrothecium verrucaria, which has the ability to inhibit the growth of breast cancer cells. However, the mechanism by which VA exerts its inhibitory potential remains elusive. Here, we demonstrated that VA inhibited the growth of MCF-7 breast cancer cells, increased the levels of reactive oxygen species (ROS), and subsequently induced mitochondrial membrane potential (Δψm) loss, leading to the increase of Bax/Bcl-2 ratio, cytochrome c release, caspase activation, PARP degradation, and apoptosis. VA effectively increased the phosphorylation of p38MAPK and diminished the phosphorylation of ERK/Akt. In addition, VA caused cell cycle deregulation through the induction of p21 and p53. Furthermore, ROS scavenger (n-acetyl-l-cysteine) and p38MAPK inhibitor (SB202190) effectively abrogated the VA-induced cell cycle deregulation and apoptosis. Conversely, U0126, an ERK1/2 inhibitor, enhanced the VA-induced apoptotic signals. Taken together, our results suggest that VA-induces apoptosis and cell cycle deregulation in MCF-7 cells through ROS-dependent p38MAPK activation.
Literatur
2.
Zurück zum Zitat Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000;33:261–74.CrossRefPubMed Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000;33:261–74.CrossRefPubMed
3.
Zurück zum Zitat Andersen B, Nielsen KF, Jarvis BB. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia. 2002;94:392–403.CrossRefPubMed Andersen B, Nielsen KF, Jarvis BB. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia. 2002;94:392–403.CrossRefPubMed
4.
Zurück zum Zitat Oda T, Namikoshi M, Akano K, Kobayashi H, Honma Y, Kasahara T. Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line. Mar Drugs. 2005;3:64–73.PubMedCentralCrossRef Oda T, Namikoshi M, Akano K, Kobayashi H, Honma Y, Kasahara T. Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line. Mar Drugs. 2005;3:64–73.PubMedCentralCrossRef
5.
Zurück zum Zitat Palanivel K, Kanimozhi V, Kadalmani B, Akbarsha MA. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-MB-231 and T47D. Biotechnol Lett. 2013;35:1395–403.CrossRefPubMed Palanivel K, Kanimozhi V, Kadalmani B, Akbarsha MA. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-MB-231 and T47D. Biotechnol Lett. 2013;35:1395–403.CrossRefPubMed
6.
Zurück zum Zitat Chen YW, Huang CF, Yang CY, Yen CC, Tsai KS, Liu SH. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol. 2010;243:323–31.CrossRefPubMed Chen YW, Huang CF, Yang CY, Yen CC, Tsai KS, Liu SH. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol. 2010;243:323–31.CrossRefPubMed
7.
Zurück zum Zitat Son YO, Hitron JA, Wang X, Chang QS, Pan JJ, Zhang Z, et al. Cr (VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol Appl Pharmacol. 2010;245:226–35.CrossRefPubMed Son YO, Hitron JA, Wang X, Chang QS, Pan JJ, Zhang Z, et al. Cr (VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol Appl Pharmacol. 2010;245:226–35.CrossRefPubMed
8.
Zurück zum Zitat Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;19:634–7.CrossRef Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;19:634–7.CrossRef
9.
Zurück zum Zitat Verma YK, Gangenahalli GU, Singh VK, Gupta P, Chandra R, Sharma RK, et al. Cell death regulation by B-cell lymphoma protein. Apoptosis. 2006;11:459–71.CrossRefPubMed Verma YK, Gangenahalli GU, Singh VK, Gupta P, Chandra R, Sharma RK, et al. Cell death regulation by B-cell lymphoma protein. Apoptosis. 2006;11:459–71.CrossRefPubMed
10.
Zurück zum Zitat Roy AM, Baliga MS, Elmets CA, Katiyar KS. Grape seed proanthocyanidins induce apoptosis through p53, Bax and caspase-3 pathways. Neoplasia. 2005;7:24–36.PubMedCentralCrossRefPubMed Roy AM, Baliga MS, Elmets CA, Katiyar KS. Grape seed proanthocyanidins induce apoptosis through p53, Bax and caspase-3 pathways. Neoplasia. 2005;7:24–36.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem. 2011;286:491–501.PubMedCentralCrossRefPubMed Du H, Wolf J, Schafer B, Moldoveanu T, Chipuk JE, Kuwana T. BH3 domains other than Bim and Bid can directly activate Bax/Bak. J Biol Chem. 2011;286:491–501.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Carvalho H, Evelson P, Sigaud S, Gonzalez-Flecha B. Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells. J Cell Biochem. 2004;92:502–13.CrossRefPubMed Carvalho H, Evelson P, Sigaud S, Gonzalez-Flecha B. Mitogen-activated protein kinases modulate H(2)O(2)-induced apoptosis in primary rat alveolar epithelial cells. J Cell Biochem. 2004;92:502–13.CrossRefPubMed
14.
Zurück zum Zitat Jung E, Byun S, Kim S, Kim M, Park D, Lee J. Isomenthone protects human dermal fibroblasts from TNF-alpha-induced death possibly by preventing activation of JNK and p38 MAPK. Food Chem Toxicol. 2012;50:3514–20.CrossRefPubMed Jung E, Byun S, Kim S, Kim M, Park D, Lee J. Isomenthone protects human dermal fibroblasts from TNF-alpha-induced death possibly by preventing activation of JNK and p38 MAPK. Food Chem Toxicol. 2012;50:3514–20.CrossRefPubMed
15.
Zurück zum Zitat Park DH, De Xu H, Shim J, Li YC, Lee JH, Cho SC, et al. Stephania delavayi Diels. inhibits breast carcinoma proliferation through the p38MAPK/NF-kappa B/COX-2 pathway. Oncol Rep. 2011;26:833–41.PubMed Park DH, De Xu H, Shim J, Li YC, Lee JH, Cho SC, et al. Stephania delavayi Diels. inhibits breast carcinoma proliferation through the p38MAPK/NF-kappa B/COX-2 pathway. Oncol Rep. 2011;26:833–41.PubMed
16.
Zurück zum Zitat Valko M, Rhodes CJ, Moncol J, Zakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.CrossRefPubMed Valko M, Rhodes CJ, Moncol J, Zakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.CrossRefPubMed
17.
Zurück zum Zitat Tamura S, Hanada M, Ohnishi M, Katsura K, Sasaki M, Kobayashi T. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem. 2002;269:1060–6.CrossRefPubMed Tamura S, Hanada M, Ohnishi M, Katsura K, Sasaki M, Kobayashi T. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem. 2002;269:1060–6.CrossRefPubMed
18.
Zurück zum Zitat Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107–15.CrossRefPubMed Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206:1107–15.CrossRefPubMed
19.
Zurück zum Zitat Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000;256:34–41.CrossRefPubMed Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000;256:34–41.CrossRefPubMed
20.
Zurück zum Zitat Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22:8983–98.CrossRefPubMed Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene. 2003;22:8983–98.CrossRefPubMed
21.
Zurück zum Zitat Zhang X, Jin B, Huang C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets. 2007;7:305–16.CrossRefPubMed Zhang X, Jin B, Huang C. The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention. Curr Cancer Drug Targets. 2007;7:305–16.CrossRefPubMed
22.
Zurück zum Zitat Trisciuoglio D, Iervolino A, Zupi G, DelBufalo D. Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell. 2005;16:4153–62.PubMedCentralCrossRefPubMed Trisciuoglio D, Iervolino A, Zupi G, DelBufalo D. Involvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cells. Mol Biol Cell. 2005;16:4153–62.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Jiang C, Wang Z, Ganther H, Lu J. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther. 2002;1:1059–66.PubMed Jiang C, Wang Z, Ganther H, Lu J. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol Cancer Ther. 2002;1:1059–66.PubMed
24.
Zurück zum Zitat Ho A, Dowdy SF. Regulation of G (1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev. 2002;12:47–52.CrossRefPubMed Ho A, Dowdy SF. Regulation of G (1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev. 2002;12:47–52.CrossRefPubMed
25.
Zurück zum Zitat Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149–63.CrossRefPubMed Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995;9:1149–63.CrossRefPubMed
26.
Zurück zum Zitat Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene. 2001;20:1063–75.CrossRefPubMed Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin M. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene. 2001;20:1063–75.CrossRefPubMed
27.
Zurück zum Zitat Winters ZE, Lee KRD, Bradburn MJ, Norbury CJ, Harris AL. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res. 2003;5:242–9.CrossRef Winters ZE, Lee KRD, Bradburn MJ, Norbury CJ, Harris AL. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res. 2003;5:242–9.CrossRef
28.
Zurück zum Zitat Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701–4.CrossRefPubMed Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 1993;366:701–4.CrossRefPubMed
29.
Zurück zum Zitat Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA protein interactions for genome stability. Nat Rev Mol Cell Biol. 2013;14:269–82.CrossRefPubMed Mailand N, Gibbs-Seymour I, Bekker-Jensen S. Regulation of PCNA protein interactions for genome stability. Nat Rev Mol Cell Biol. 2013;14:269–82.CrossRefPubMed
Metadaten
Titel
Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7
verfasst von
Kandasamy Palanivel
Veerasamy Kanimozhi
Balamuthu Kadalmani
Publikationsdatum
01.10.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 10/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2286-1

Weitere Artikel der Ausgabe 10/2014

Tumor Biology 10/2014 Zur Ausgabe

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Brustkrebs-Prävention wird neu gedacht

04.06.2024 ASCO 2024 Kongressbericht

Zurzeit untersuchen Forschende verschiedene neue Ansätze zur Prävention von Brustkrebs bei Personen mit hohem Risiko. Darunter Denosumab, die prophylaktische Bestrahlung der Brust – und Impfungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.